RA: 20-y data support early treatment
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
Why this matters
- ET and late treatment (LT) groups had lower mortality risk vs no treatment (NT), but age- and sex-adjusted mortality rates were similar among all groups.
- Over time, ET group and NT group had similar disability levels, whereas LT group had higher.
- 20-y average HAQ score was 1.38, representing low to moderate disability—an improvement vs an earlier study that measured a cohort recruited in the 1960s.
- The researchers assessed 602 RA patients who joined the prospective Norfolk (UK) Arthritis Register between 1990 ...